Serial block-face scanning electron microscopy applied to study the trafficking of 8D3-coated gold nanoparticles at the blood–brain barrier
暂无分享,去创建一个
Manel Bosch | Jordi Vilaplana | I. Prior | Ian A Prior | C. Pelegrí | J. Vilaplana | A. Beckett | Alison J. Beckett | Itsaso Cabezón | Elisabet Augé | Alison J Beckett | Carme Pelegrí | I. Cabezón | M. Bosch | Elisabet Augé
[1] C. Peddie,et al. Exploring the third dimension: volume electron microscopy comes of age. , 2014, Micron.
[2] T. Deerinck,et al. NCMIR methods for 3D EM: a new protocol for preparation of biological specimens for serial block face scanning electron microscopy , 2010 .
[3] E. Morgan,et al. Restricted transport of anti‐transferrin receptor antibody (OX26) through the blood–brain barrier in the rat , 2001, Journal of neurochemistry.
[4] F. Calon,et al. In Vivo Labeling of Brain Capillary Endothelial Cells after Intravenous Injection of Monoclonal Antibodies Targeting the Transferrin Receptor , 2011, Molecular Pharmacology.
[5] W. Pardridge,et al. Delivery of β-Galactosidase to Mouse Brain via the Blood-Brain Barrier Transferrin Receptor , 2005, Journal of Pharmacology and Experimental Therapeutics.
[6] F. Calon,et al. Intravenous nonviral gene therapy causes normalization of striatal tyrosine hydroxylase and reversal of motor impairment in experimental parkinsonism. , 2003, Human gene therapy.
[7] Johannes E. Schindelin,et al. Fiji: an open-source platform for biological-image analysis , 2012, Nature Methods.
[8] P. Freskgård,et al. Antibody therapies in CNS diseases , 2017, Neuropharmacology.
[9] Davi D Bock,et al. Volume electron microscopy for neuronal circuit reconstruction , 2012, Current Opinion in Neurobiology.
[10] J. del Valle,et al. Study of the transcytosis of an anti-transferrin receptor antibody with a Fab' cargo across the blood-brain barrier in mice. , 2013, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[11] G. Storm,et al. Targeting Anti—Transferrin Receptor Antibody (OX26) and OX26-Conjugated Liposomes to Brain Capillary Endothelial Cells Using In Situ Perfusion , 2004, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[12] Drug targeting to the brain. , 2007, Annual review of pharmacology and toxicology.
[13] B. Asselbergh,et al. Developing 3D SEM in a broad biological context , 2015, Journal of microscopy.
[14] E. Shusta,et al. Targeting receptor-mediated transport for delivery of biologics across the blood-brain barrier. , 2015, Annual review of pharmacology and toxicology.
[15] W. Pardridge,et al. CNS Drug Design Based on Principles of Blood‐Brain Barrier Transport , 1998, Journal of neurochemistry.
[16] Satoshi Shimo,et al. Conductive resins improve charging and resolution of acquired images in electron microscopic volume imaging , 2016, Scientific Reports.
[17] B. Engelhardt,et al. Targeting rat anti-mouse transferrin receptor monoclonal antibodies through blood-brain barrier in mouse. , 2000, The Journal of pharmacology and experimental therapeutics.
[18] P. Couvreur,et al. Nanocarriers’ entry into the cell: relevance to drug delivery , 2009, Cellular and Molecular Life Sciences.
[19] S. Saitoh,et al. Three-dimensional volume imaging with electron microscopy toward connectome. , 2015, Microscopy.
[20] A. Rees,et al. Vector-mediated drug delivery to the brain , 2001, Expert opinion on biological therapy.
[21] F. Calon,et al. Brain uptake of a fluorescent vector targeting the transferrin receptor: a novel application of in situ brain perfusion. , 2014, Molecular pharmaceutics.
[22] David J. Begley,et al. Structure and function of the blood–brain barrier , 2010, Neurobiology of Disease.
[23] A. Camins,et al. Trafficking of Gold Nanoparticles Coated with the 8D3 Anti-Transferrin Receptor Antibody at the Mouse Blood-Brain Barrier. , 2015, Molecular pharmaceutics.